Demerol
Home >> Demerol >> Drug Details
Pethidine (INN) or meperidine (USAN) (commonly referred to as Demerol but also referred to as: isonipecaine; lidol; pethanol; piridosal; Algil; Alodan; Centralgin; Dispadol; Dolantin; Mialgin (in Romania); Petidin Dolargan (in Poland);[1] Dolestine; Dolosal; Dolsin; Mefedina) is a fast-acting opioid analgesic drug. In the United States and Canada, it is more commonly known as meperidine or by its brand name Demerol.[2]
Pethidine is indicated for the treatment of moderate to severe pain, and is delivered as its hydrochloride salt in tablets, as a syrup, or by intramuscular or intravenous injection. For much of the 20th century, pethidine was the opioid of choice for many physicians; in 1983 60% of doctors prescribed it for acute pain and 22% for chronic severe pain.[3]
Compared to morphine, pethidine was supposed to be safer and carry less risk of addiction, and to be superior in treating the pain associated with biliary spasm or renal colic due to its putative antispasmodic effects. In fact, pethidine is no more effective than morphine at treating biliary or renal pain, and its low potency, short duration of action, and unique toxicity (i.e., seizures, delirium, other neuropsychological effects) relative to other available opioid analgesics have seen it fall out of favor in recent years for all but a very few, very specific indications.[4] Several countries, including Australia, have put strict limits on its use.[5] Nevertheless, some physicians continue to use it as a first line strong opioid.
Pharmacodynamics/mechanism of action
Pethidine's efficacy as an analgesic was discovered almost accidentally; it was synthesized in 1939 at an IG Farben laboratory as an antimuscarinic agent.[6] Pethidine also has structural similarities to atropine and other tropane alkaloids and may have some of their effects and side effects.[1] Pethidine exerts its analgesic effects by the same mechanism as morphine, by acting as an agonist at the -opioid receptor. In addition to its strong opioidergic and anticholinergic effects, it has local anesthetic activity related to its interactions with sodium ion channels.
Pethidine's apparent in vitro efficacy as an "antispasmodic" is due to its local anesthetic effects. It does not, contrary to popular belief, have antispasmodic effects in vivo.[7] Pethidine also has stimulant effects mediated by its inhibition of the dopamine transporter (DAT) and norepinephrine transporter (NAT). Because of its DAT inhibitory action, pethidine will substitute for cocaine in animals trained to discriminate cocaine from saline.[8]
Several analogues of pethidine have been synthesized that are potent inhibitors of the reuptake of the monoamine neurotransmitters dopamine and norepinephrine via DAT and NAT.[9][10] It has also been associated with cases of serotonin syndrome, suggesting some interaction with serotonergic neurons, but the relationship has not been definitively demonstrated.[5][6][8][10] It is more lipid-soluble than morphine, resulting in a faster onset of action. Its duration of clinical effect is 120150 minutes although it is typically administered in 4-6 hour intervals. Pethidine has been shown to be less effective than morphine, diamorphine or hydromorphone at easing severe pain, or pain associated with movement or coughing.[6][8][10]
Like other opioid drugs, pethidine has the potential to cause physical dependence or addiction. In fact, pethidine may be more addictive than other opioids because of its exceptionally rapid onset of action and associated "rush", and additional activity as a monoamine transporter inhibitor, which results in cocaine-like stimulant effects in addition to its typical opioid effects.[11] When compared with oxycodone, hydromorphone, and placebo, pethidine was consistently associated with more euphoria, difficulty concentrating, confusion, and impaired psychomotor and cognitive performance when administered to healthy volunteers.[12] The especially severe side effects unique to pethidine among opioids serotonin syndrome, seizures, delirium, dysphoria, tremor are primarily or entirely due to the action of its metabolite, norpethidine.[6][13]); accumulating with regular administration, or in renal failure. Norpethidine is toxic and has convulsant and hallucinogenic effects. The toxic effects mediated by the metabolites cannot be countered with opioid receptor antagonists such as naloxone or naltrexone and are probably primarily due to norpethidine's anticholinergic activity probably due to its structural similarity to atropine though its pharmacology has not been thoroughly explored. The neurotoxicity of pethidine's metabolites is a unique feature of pethidine compared to other opioids. Pethidine's metabolites are further conjugated with glucuronic acid and excreted into the urine.

Interactions
Pethidine has serious interactions that can be dangerous with MAOIs (e.g., furazolidone, isocarboxazid, moclobemide, phenelzine, procarbazine, selegiline, tranylcypromine). Such patients may suffer agitation, delirium, headache, convulsions, and/or hyperthermia. Fatal interactions have been reported including the death of Libby Zion.[14] It is thought to be caused by an increase in cerebral serotonin concentrations. It is possible that Pethidine can also interact with a number of other medications, including muscle relaxants, some antidepressants, benzodiazepines, and alcohol.
Pethidine is also relatively contraindicated for use when a patient is suffering from liver, or kidney disease, has a history of seizures or epilepsy, has an enlarged prostate or urinary retention problems, or suffers from hypothyroidism, asthma, or Addison's disease.
Adverse effects
In addition to the adverse effects common to all opioids, such as constipation, dry mouth, lightheadedness, twitchiness, muscular twitches, and nausea, the repeated administration[citation needed] of pethidine can lead to neurotoxic effects. Pethidine is least harmful when not administered by the intravenous route as there is a serious risk of triggering histamine release.[5] However, most opioid-addicts who abuse Demerol prefer to use intravenously as opposed to any other method, in order, with intra-muscular as second, rectally, insufflation & orally.[citation needed] For harm reduction[weasel words] or if you are particularly sensitive to meperidine's histamine release, the use of a low-to-moderate dose anti-histamine (Cyclizine preferrably if available), Doxylamine, Meclizine, etc.) 2530 minutes before injecting Meperidine intravenously.[citation needed] When seen used in hospital settings its frequently combined with Atarax/VistarilHydroxyzine, an opioid-boosting anti-histamine which prevents or lessens itching, swelling and other histamine effects as well as increasing analgesia.[citation needed]
Hazardous use, harmful use, dependence, and diversion
Notable individuals
Well-known people who have died of pethidine use include:
Trends
In data from the U.S. Drug Abuse Warning Network, mentions of hazardous or harmful use of pethidine declined between 1997 and 2002, in contrast to increases for fentanyl, hydromorphone, morphine, and oxycodone.[16] The number of dosage units of pethidine that were reported lost or stolen in the U.S. increased 16.2% between 2000 and 2003, from 32,447 to 37,687.[17]
Notes
This article uses the terms "hazardous use," "harmful use," and "dependence" in accordance with Lexicon of alcohol and drug terms published by the World Health Organization (WHO) in 1994. [18] In WHO usage, the first two terms replace the term "abuse" and the third term replaces the term "addiction." [18]
References
- ^ "Lekopedia - Dolargan". jestemchory.pl. http://www.jestemchory.pl/lek.via?id=99824&str=19&l=d&r=h&VSID=4c69dc1b3a23b828e497dea2157f0263. Retrieved 2006-08-01.
- ^ Demerol RxList. Retrieved 19 Jun. 2006.
- ^ Kaiko, Robert F.; Kathleen M. Foley, Patricia Y. Grabinski, George Heidrich, Ada G. Rogers, Charles E. Inturrisi, Marcus M. Reidenberg (February 1983). "Central Nervous System Excitatory Effects of Meperidine in Cancer Patients". Annals of Neurology (Wiley Interscience) 13 (2): 180185. doi:10.1002/ana.410130213. ISSN: 0364-5134.
- ^ Donna Wong (2002-03-15). "Notes on Meperidine". Wong on Web Papers. Elsevier. http://www.mosbysdrugconsult.com/WOW/op024.html. Retrieved 2007-04-13.
- ^ a b c Davis, Sharon (August 2004). "Use of pethidine for pain management in the emergency department: a position statement of the NSW Therapeutic Advisory Group" (PDF). New South Wales Therapeutic Advisory Group. http://www.clininfo.health.nsw.gov.au/nswtag/publications/posstats/Pethidinefinal.pdf. Retrieved 2007-01-17.
- ^ a b c d Latta, Kenneth S.; Brian Ginsberg, Robert L. Barkin (January/February 2002). "Meperidine: A Critical Review". American Journal of Therapeutics (Lippincott Williams & Wilkins) 9 (1): 5368. doi:10.1097/00045391-200201000-00010. ISSN: 1075-2765.
- ^ Wagner, Larry E., II; Michael Eaton, Salas S. Sabnis, Kevin J. Gingrich (November 1999). "Meperidine and Lidocaine Block of Recombinant Voltage-Dependent Na+ Channels: Evidence that Meperidine is a Local Anesthetic". Anesthesiology (Lippincott Williams & Wilkins) 91 (5): 14811490. doi:10.1097/00000542-199911000-00042. ISSN: 0003-3022.
- ^ a b c Izenwasser, Sari; Amy Hauck Newman, Brian M. Cox, Jonathan L. Katz (January/February 1996). "The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter". European Journal of Pharmacology (Elsevier) 297 (1-2): 917. doi:10.1016/0014-2999(95)00696-6. ISSN: 0014-2999.
- ^ Lomenzo, Stacey A.; Jill B. Rhoden, Sari Izzenwasser, Dean Wade, Theresa Kopajtic, Jonathan L. Katz, Mark L. Trudell (2005-03-05). "Synthesis and Biological Evaluation of Meperdine Analogs at Monoamine Transporters". Journal of Medicinal Chemistry (American Chemical Society) 48 (5): 13361343. doi:10.1021/jm0401614. ISSN: 0022-2623.
- ^ a b c "Demerol: Is It the Best Analgesic?" (PDF). Pennsylvania Patient Safety Reporting Service Patient Safety Advisory (Pennsylvania Patient Safety Authority) 3 (2). June 2006. http://www.psa.state.pa.us/psa/lib/psa/advisories/v3n2june2006/junevol_3_no_2_article_g_demerol.pdf. Retrieved 2007-01-16.
- ^ "In Brief". NPS Radar. National Prescribing Service. December 2005. http://www.npsradar.org.au/site.php?page=1&content=/npsradar/content/latestnews.html. Retrieved 2007-01-17.
- ^ Walker, Diana J.; James P. Zacny (June 1999). "Subjective, Psychomotor, and Physiological Effects of Cumulative Doses of Opioid µ Agonists in Healthy Volunteers". The Journal of Pharmacology and Experimental Therapeutics (American Society for Pharmacology and Experimental Therapeutics) 289 (3): 14541464.
- ^ Norpethedine half-life. 2002. Australian prescriber
- ^ Brody, Jane (February 27, 2007). "A Mix of Medicines That Can Be Lethal". New York Times. http://www.nytimes.com/2007/02/27/health/27brody.html?n=Top/News/Health/Diseases,%20Conditions,%20and%20Health%20Topics/Antidepressants. Retrieved 2009-02-13. "The death of Libby Zion, an 18-year-old college student, in a New York hospital on March 5, 1984, led to a highly publicized court battle and created a cause célèbre over the lack of supervision of inexperienced and overworked young doctors. But only much later did experts zero in on the preventable disorder that apparently led to Ms. Zions death: a form of drug poisoning called serotonin syndrome."
- ^ Stuart, Reginald (1984-05-17). "3 Drugs are Blamed in David Kennedy Case". New York Times. http://www.nytimes.com/1984/05/17/us/3-drugs-are-blamed-in-david-kennedy-case.html. Retrieved 2009-06-25.
- ^ Gilson AM, Ryan KM, Joranson DE, Dahl JL (2004). "A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002". J Pain Symptom Manage 28 (2): 176-188. doi:10.1016/j.jpainsymman.2004.01.003. http://download.journals.elsevierhealth.com/pdfs/journals/0885-3924/PIIS0885392404001824.pdf.
- ^ Joranson DE, Gilson AM (2005). "Drug crime is a source of abused pain medications in the United States". J Pain Symptom Manage 30 (4): 299-301. doi:10.1016/j.jpainsymman.2005.09.001. http://download.journals.elsevierhealth.com/pdfs/journals/0885-3924/PIIS088539240500477X.pdf.
- ^ a b Babor T, et al., compilers (1994). Lexicon of alcohol and drug terms. Geneva: World Health Organization. ISBN 9241544686. http://whqlibdoc.who.int/publications/9241544686.pdf.
|
Serotonergics |
|
Receptor
Ligands |
|
|
|
|
|
|
|
|
|
|
|
|
Agonists: Lysergamides: Dihydroergotamine Methysergide; Triptans: Almotriptan Eletriptan Frovatriptan Naratriptan Rizatriptan Sumatriptan Zolmitriptan; Tryptamines: 5-CT 5-MT; Others: CP-135,807 CP-286,601 GR-46611 L-694,247 L-772,405 PNU-109,291 PNU-142,633
Antagonists: Lysergamides: Metergoline Methiothepin; Tryptamines: Rauwolscine Yohimbine; Others: BRL-15572 GR-127,935 Ketanserin LY-310,762 LY-367,642 LY-456,219 LY-456,220 Ritanserin Ziprasidone
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agonists: Phenethylamines: 2C-B 2C-E 2C-I 2C-T-2 2C-T-7 2C-T-21 DOB DOC DOI DOM MDA MDMA Mescaline Myristicin; Piperazines: Aripiprazole mCPP TFMPP; Tryptamines: 5-CT 5-MeO--ET 5-MeO--MT 5-MeO-DET 5-MeO-DiPT 5-MeO-DMT 5-MeO-DPT 5-MT -ET -Methyl-5-HT -MT Bufotenin DET DiPT DMT DPT Psilocin Psilocybin; Others: A-372,159 AL-38022A CP-809,101 Lorcaserin MK-212 PNU-22394 Ro60-0175 Vabicaserin WAY-629 WAY-161,503 YM-348
Antagonists: Atypical Antipsychotics: Clozapine Iloperidone Melperone Olanzapine Paliperidone Pimozide Quetiapine Risperidone Sertindole Ziprasidone Zotepine; Typical Antipsychotics: Chlorpromazine Loxapine Pipamperone; Antidepressants: Agomelatine Amitriptyline Amoxapine Etoperidone Fluoxetine Mianserin Mirtazapine Nefazodone Nortriptyline Trazodone; Others: Cinanserin Cyproheptadine Deramciclane Dimebolin Dotarizine Eltoprazine FR-260,010 Ketanserin Ketotifen Methysergide Pizotifen Ritanserin RS-102,221 SB-200,646 SB-206,553 SB-221,284 SB-228,357 SB-242,084 SB-243,213 SDZ SER-082 Xylamidine
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5-HT5B*
|
Agonists: Lysergamides: Ergotamine LSD
Antagonists: Methiothepin
* Note that the 5-HT5B receptor is not functional in humans.
|
|
|
|
|
|
|
|
|
|
|
|
Reuptake
Inhibitors |
|
|
Releasing
Agents |
|
|
Enzyme
Inhibitors |
|
|
| Others |
|
|
Recent Demerol Forums View All 
Return to Top Start a New Discussion About this Drug
This article is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License) http://en.wikipedia.org/wiki/Meperidine
This information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for face to face medical advice from a qualified healthcare professional. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved.
drug_details.asp Last Updated July 19 2009
|
Home Page
Post Your Story or Question
Follow Us On Twitter
Registered Community Experts
Topics Submitted 
Prescription Drug Forums 
Top 200 Prescription Drugs
Drugs by Category
Recent FDA Approvals
November 2009 Health News
Advertising & Contact Details
About the Community
Medical Disclaimer
Terms of Use
Privacy Policy
Make Us Your Home Page
Bookmark this Page 
Recent Topics
A101
M Cap
Jevity
Wl 32
White Oblong G 13
V 5092
Round Pink Pill With Ip On It
N20 On One Side M Pink Pill
4211
Ip Round Pink
Little Blue Pill With G
Tera
Ip Round
Tussigon
Al Cozaar
Peach Oblong 5 Die
Mylan A1
Denafil
Small Round White Pill With Scored On One Side
Azilect
E65
Flonorm
Chlorpromazine
Blue And Red Capsule 933171
Il Doloneuron
Small Round Pill With Top One Side And 25 On It
Zyprexa
Pill In The Shape Of Letter D
Suprazole 200
List Of Eye Medications
|